Job ID: 700508624
Job date: 2018-05-21
End Date: 2018-07-20
Company : Seres Therapeutics Country : United States Role : Research Scientist
Job date: 2018-05-21
End Date: 2018-07-20
Company : Seres Therapeutics Country : United States Role : Research Scientist
Job Description:
What's Your Mission? You will use your training and education to develop quantitative methods, metrics, and analytical procedures for evaluating and interpreting microbiome datasets to identify disease targets and design Ecobiotic® therapeutics. You will follow these therapeutics through clinical development, driving the analysis of clinical genomic and metabolomic data to support the evaluation of drug mechanism of action, pharmacokinetics and pharmacodynamics. What You'll Do:
Additional Info:
Why Seres Therapeutics At Seres Therapeutics, we have a singular mission to transform the lives of patients by targeting the microbiome. We are pioneers and explorers, charting a new course. If you have a pioneering spirit, come join us as we spark the revolution to treat disease through the microbiome. Who We Are: Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious and inflammatory diseases. For more information, please visit http://serestherapeutics.com/ SDL2017[Click Here to Access the Original Job Post]
What's Your Mission? You will use your training and education to develop quantitative methods, metrics, and analytical procedures for evaluating and interpreting microbiome datasets to identify disease targets and design Ecobiotic® therapeutics. You will follow these therapeutics through clinical development, driving the analysis of clinical genomic and metabolomic data to support the evaluation of drug mechanism of action, pharmacokinetics and pharmacodynamics. What You'll Do:
- Leverage high throughput amplicon, metagenomics, systems biology, and comparative genomic approaches to identify the ecological and functional microbial signatures of health and disease states in infectious, inflammatory disease and immuno-oncology
- Work closely with teams across the organization to translate critical insights in the field of the human microbiome into the discovery of therapeutic microbial compositions for the treatment of diseases and elucidation of their mechanisms of action
- Contribute to the development of the company's intellectual property portfolio and support regulatory filings for key infectious disease and immuno-oncology programs
- At least 3 years of demonstrated experience analyzing and interpreting genomic, transcriptomic, and metabolomic data sets from clinical studies or cohort studies, with rich experience in bioinformatics and/or statistical analysis of high-dimensional biological data sets.
- Proficiency in at least one analytical language (e.g. R or Matlab) and/or programing skills in one or more languages (preferred: Python, Perl, or C++)
- a Ph.D. or Master's degree in microbial genomics, computational biology, microbiology, or other related scientific field
Requeriments :
Skills :
- Bioinformatics
- genomic
- immunology
- Programing in C++
- Programing in Python
- Programing Skills
- Programming in Matlab
- Programming in PERL
- Programming in R
- Statistics
- Transcriptomics
Areas :
Additional Info:
Why Seres Therapeutics At Seres Therapeutics, we have a singular mission to transform the lives of patients by targeting the microbiome. We are pioneers and explorers, charting a new course. If you have a pioneering spirit, come join us as we spark the revolution to treat disease through the microbiome. Who We Are: Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious and inflammatory diseases. For more information, please visit http://serestherapeutics.com/ SDL2017[Click Here to Access the Original Job Post]